BioXpress Therapeutics SA
High-quality biosimilar biologic APIs for unmet need indications
BioXpress Therapeutics SA is a premier partner for high-quality biosimilar biologics for unmet need indications such as cancer, inflammation and autoimmunity, including adaptive immunity. We have made a commitment to be your partner of choice for the full development of your biosimilar biologic. BioXpress Therapeutics is focused on developing the highest quality product under strict European Medicines Agency (EMA) guidelines. We bring together the world’s top biologic development, manufacturing and regulatory experts dedicated to your project.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
BioXpress Therapeutics SA
High-quality biosimilar biologic APIs for unmet need indications
Website:
bioxpress.com/
Headquarter:
Plan-les-Quates
Foundation Date:
May 2008
Technology:
- Biotech
Sectors:
- Biomaterials
- Cancer
Support received
